SCOPUS 정보 검색 플랫폼

International Journal of Antimicrobial Agents

Volumn 16, Issue 2, 2000, Pages 185-187

Multinational cooperation in trials and guidelines dealing with febrile neutropenia

(1) Feld, Ronald a

a PRINCESS MARGARET HOSPITAL (Canada)

Author keywords

Antimicrobials; Febrile neutropenia; Multinational cooperation

Indexed keywords

AMPHOTERICIN B; ANTIBIOTIC AGENT; ANTIFUNGAL AGENT; ANTIINFECTIVE AGENT; ANTIVIRUS AGENT; VANCOMYCIN;

ARTICLE; CANCER PATIENT; COOPERATION; FEBRILE NEUTROPENIA; HIGH RISK PATIENT; HUMAN; IMMUNE DEFICIENCY; INFECTION; MORTALITY; PRACTICE GUIDELINE; PRIORITY JOURNAL;

ANTIBIOTICS; CLINICAL TRIALS; FEVER; HUMAN; IMMUNOCOMPROMISED HOST; INFECTION; INTERNATIONAL COOPERATION; NEOPLASMS; NEUTROPENIA; PRACTICE GUIDELINES;

EID: 0033772052 PISSN: 09248579 EISSN: None Source Type: Journal
DOI: 10.1016/S0924-8579(00)00240-5 Document Type: Article

Times cited : (13)

References (10)

1
- 0007496791
- EORTC International Antimicrobial Therapy Cooperative Group. Empiric antifungal therapy in febrile granulocytopenic patients. Am J Med 1989;86:668-672.

2
- 0007532274
- International Antimicrobial Therapy Cooperative Group and National Cancer Institute of Canada-Clinical Trials Group. Vancomycin added to empirical combination antibiotic therapy for fever in granulocytopenic cancer patients. J Infect Dis 1991;163:951-958.

3
- 0028270891
- Factors associated with bacteremia in febrile granulocytopenic cancer patients
- (1994) Eur. J. Cancer , vol.30 A , pp. 430-437
- Viscoli, C.¹ Bruzzi, P.² Castagnola, L.³

4
- 0007574827
- Kern WV, Cometta A, DeBock R et al. for the International Antimicrobial Cooperative Group of the European Organization for Research and Treatment of Cancer. Oral versus intravenous empirical antimicrobial therapy for fever in patients with granulocytopenia who are receiving cancer chemotherapy. N Engl J Med 1999;341:312-318.

5
- 0007534927
- Consensus Panel of the Immunocompromised Host Society. The design analysis and reporting of clinical trials on the empirical antibiotic management of the neutropenic patient. J Infect Dis 1990;161:397-401.

6
- 0026442754
- Evaluation of new anti-infective drugs for the treatment of febrile episodes in neutropenic patients
- (1992) Clin. Infect. Dis. , vol.15 , Issue.Supp.1
- Hughes, W.T.¹ Armstrong, D.² Wade, J.C.³ Armstrong, D.⁴ Webb, D.⁵ Young, L.S.⁶

7
- 0007492331
- Klastersky J for MASCC. Prognostic factors for outcome in cancer patients (PTS) with febrile neutropenia (FN): A multinational survey from the infection committee of the Multinational Association for Supportive Care in Cancer (MASCC). Proc of the 34th Annual Meeting of The American Society of Clinical Oncology (ASCO) 1998;17:419a (Abstract # 1615).

8
- 0007534928
- Klastersky J for MASCC. A predictive model to identify cancer patients (pts) with febrile neutropenia (FN) at low risk to develop a serious medical complication: results from a multinational survey conducted by the Infection study section of the Multinational Association for Supportive Care in Cancer (MASCC). Proc of the 23rd Congress of The European Society for Medical Oncology (ESMO) Annals of Oncology 1998;9 (Suppl 4):140 (Abstract #6740).

9
- 0007536369
- Hughes WT, Chairman, Armstrong D, Bodey GP et al. From the Infectious Diseases Society of America: Guidelines for the use of antimicrobial agents in neutropenic patients with unexplained fever. J Infect Dis 1990;161:381-396.

10
- 0031227964
- Guidelines from the Infectious Diseases Society of America. Guidelines for the use of antimicrobial agents in neutropenic patients with unexplained fever
- (1997) Clin. Infect. Dis. , vol.25 , pp. 551-573
- Hughes, W.T.¹ Armstrong, D.² Bodey, G.P.³

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.